Global Animal Sedative Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

They are employed as tranquilizers, preanesthetic drugs, antiemetics, and for the treatment of CNS agitation in domestic animals.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, September 27, 2021
Information
Tags: 
Veterinary, Health, Adoption, CNS, Lists of countries and territories, Animal, Thioridazine, Chlorpromazine, Zoonosis, Acepromazine, Canine influenza, Growth, Trifluoperazine, Awareness, Medicine, Dopamine, Research, Allergy, Rabies, Antiemetic, Agitation, Veterinary medicine, Phenothiazine, Government, Pharmaceutical industry
Geotags: 
NORTH AMERICA, JAPAN, EUROPE, CHINA, INDIA, ASIA, NORTH
⚠generated by AI ↴
Summary
Key Points: 
  • They are employed as tranquilizers, preanesthetic drugs, antiemetics, and for the treatment of CNS agitation in domestic animals.
  • The animals are provided sedative drugs for their cure from zoonoses, phenothiazines being the parent ingredient for the most regularly used sedative drugs.
  • Hence, the increase in the demand of this segment will drive the overall animal sedative market.
  • This, together with the rising frequency of animal diseases, will help this region maintain its market dominance in the years ahead.


The "Animal Sedative Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

The animal sedative market is projected to register a CAGR of 5.1% during the forecast period.

Companies Mentioned

  • Zoetis, Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co. Inc.
  • Elanco
  • Virbac Group
  • Dechra Pharmaceuticals Plc
  • Orion Corporation
  • Vetoquinol
  • Ceva

Key Market Trends

The Phenothiazines drug Segment is Expected to Account for the Largest Market Share During the Forecast Period

The phenothiazines segment is estimated to have the highest share of the animal sedatives market during the forecast period, as they aid to lower dopamine levels and further depress some areas of the reticular activating systems. Acepromazine is one of the most regularly used phenothiazines, which can be used alone or in combination with other sedatives as pre-operative drugs, to relieve travel anxiety, and to avoid allergies and itching in animals.

The parent ingredient of all medications is a phenothiazine. They are employed as tranquilizers, preanesthetic drugs, antiemetics, and for the treatment of CNS agitation in domestic animals. Chlorpromazine (marketed as Thorazine and other trade names), thioridazine (Mellaril), and trifluoperazine are three of the most often utilized phenothiazines (Stelazine).

Animal diseases such as Rabies, Canine distemper, Leptospirosis, Canine influenza, Canine parainfluenza, etc. are some of the most common risks for the animal's well-being. The animals are provided sedative drugs for their cure from zoonoses, phenothiazines being the parent ingredient for the most regularly used sedative drugs. Hence, the increase in the demand of this segment will drive the overall animal sedative market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America held the largest market for animal sedative drugs in the past and is expected to retain its position during the forecast period due to an increase in the frequency of zoonotic diseases, the use of animal sedatives, and increased expenditure in animal medical research. The presence of well-established healthcare infrastructure, and strong adoption of the latest diagnostic technology are all factors that contribute to this supremacy. This, together with the rising frequency of animal diseases, will help this region maintain its market dominance in the years ahead.

The North American region is estimated to be a potential segment for the animal sedative market as it generates most of the revenue from this region, because of the presence of comparatively higher animal health expenditure, high awareness levels, and a large number of medical research and trials. North America is expected to dominate the animal sedative market during the forecast period because of the government initiatives of monitoring and implementation of rules and regulations on sedatives drug manufacturing companies.

Moreoever, Europe and Asia Pacific is also expected to account for significant growth during the forecast period due to large incidences of medical research and improving animal healthcare infrastructure in the developing countries like China, Japan and India. Additionally, increase in expenditure on research and development activities for improving animal's safety and care is the strategy adopted by the dominating market players to account for the industry growth in the region.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rise in Incidence of Zoonotic Diseases

4.2.2 Increasing Incidence of Animal Cancer

4.2.3 Growing Investment in R&D activities to Ensure Quality and Care for Animals

4.3 Market Restraints

4.3.1 Adverse Effects of Animal Sedative Drugs

4.3.2 Stringent Government Regulations for the Sedatives

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Drug Class

5.2 By Application

5.3 By Route of Administration

5.4 By Animal Type

5.5 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/s760pi

Copyright: 
Copyright Business Wire 2021